Featured
Malaria vaccine: 77% efficacy
EDCTP-funded phase II clinical trial in Burkina Faso demonstrates that malaria vaccine candidate R21/Matrix-M is safe, immunogenic and has an efficacy of 77%.
Tenth EDCTP Forum
The Tenth EDCTP Forum 'Equity in Research for Health' will take place from 17-21 October 2021.
Registration is now open.
EDCTP Update September 2021
EDCTP’s monthly electronic newsletter | Tenth EDCTP Forum, project news, events, funding and resources
Projects
Access our online projects database and guidance information to manage EDCTP2 grants.
Achievements
See our achievements in bringing together research from Europe and Africa and developing research capacity in sub-Saharan Africa.
News
12 October 2021
First EDCTP and Africa CDC-supported Epidemiologists and Biostatisticians start their training
07 October 2021
RTS,S/AS01 malaria vaccine: EDCTP contributions and next steps
14 September 2021
African Union and EDCTP sign Memorandum of Understanding to promote new paradigm in health
Latest Tweets
RT @dsw_intl: On October 20, we will join the Tenth @EDCTP Forum with a virtual symposium on the impacts of #COVID19 on poverty-related and…See the post
1 day ago
RT @MedsforMalaria: MMV & partners at the Tenth @EDCTP Forum (17-21 Oct)
🟠 Pyramax to treat uncomplicated malaria (MMV)
🟠 IPTi for childre…See the post
1 day ago
RT @WWARN: We are presenting some of our latest research on #malaria and #DataSharing at the 10th #EDCTPForum, Oct 17-21, find out more: ht…See the post
1 day ago